Northern Trust Corp Sells 141,077 Shares of Option Care Health, Inc. $OPCH

Key Points

• Northern Trust Corp has reduced its stake in Option Care Health, Inc. by 5.4%, now owning 1.52% of the company valued at approximately $86.87 million.
• Recent quarterly results posted an earnings per share (EPS) of $0.41, surpassing expectations, while revenue increased 15.4% year-over-year to $1.42 billion.
• Institutional investors hold a significant 98.05% of Option Care Health’s stock, with several hedge funds making substantial new acquisitions during the last quarter.

Northern Trust Corp cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 5.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,485,401 shares of the company's stock after selling 141,077 shares during the period. Northern Trust Corp owned 1.52% of Option Care Health worth $86,865,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Public Employees Retirement System of Ohio increased its stake in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the period. US Bancorp DE increased its stake in shares of Option Care Health by 5.0% during the first quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after buying an additional 393 shares during the period. State of Michigan Retirement System increased its stake in shares of Option Care Health by 1.2% during the first quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock valued at $1,425,000 after buying an additional 500 shares during the period. Louisiana State Employees Retirement System grew its stake in Option Care Health by 1.1% in the first quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock worth $1,667,000 after purchasing an additional 500 shares during the period. Finally, State of Alaska Department of Revenue grew its stake in Option Care Health by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after purchasing an additional 525 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. JMP Securities upped their price target on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Option Care Health has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Down 0.2%

Option Care Health stock traded down $0.07 during mid-day trading on Friday, hitting $28.68. The company had a trading volume of 1,554,512 shares, compared to its average volume of 1,808,057. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock's 50 day moving average price is $29.60 and its two-hundred day moving average price is $31.65. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a market capitalization of $4.65 billion, a PE ratio of 22.94, a price-to-earnings-growth ratio of 1.75 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the stock in a transaction dated Wednesday, August 20th. The shares were purchased at an average cost of $27.15 per share, with a total value of $977,400.00. Following the completion of the acquisition, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction dated Thursday, August 21st. The shares were acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.